|
|
Pharmaceutical Particle Counting Papers
N E W |
EU GMP 5 µm Particle Counter Limits Advice (860.1 KB)
There is a common industry misconception that 1m3 particle monitoring should be performed...(download file to continue to learn more)
Download above file for full tables and figures, or for overview, see HTML Version.
|
|
Particle Counters for Pharmaceutical Cleanrooms (381.5 KB)
This paper explains the various microcontamination requirements of pharmaceutical manufacturing, defines a clean manufacturing environment, and shows how to...
Download above file for full tables and figures, or for overview, see HTML Version.
|
N E W |
Particle Counters for Injectable Solutions, 2007 USP Update (244.3 KB)
Learn about the requirements laid out by US (USP), European (EP), and Japanese (JP) Pharmacopoeia standards, including the most recent USP 788 (April 2007), EP 5.1 and JP 15 release information. These standards demand that...
Download above file for full tables and figures, or for overview, see HTML Version.
|
N E W |
Planning and Installing an Environmental Particle Monitoring System (489.4 KB)
For aseptic manufacture of pharmaceutical products, there has been a shift, primarily due to legislative regulations. New regulations have led to a requirement for an automated, remote monitoring solution. This paper reviews the various steps for the implementation of ...
Download above file for full tables and figures, or for overview, see HTML Version.
|
|
21 CFR 1271 Particle Monitoring Requirements for Human Cell, Tissue, and Cellular and Tissue-Based Products (HCT/P) (591.4 KB)
The FDA requires human cell, tissue, and cellular and tissue-based product establishments to follow the current Good Tissue Practice (GTP), which governs the methods used in, and the facilities and controls used for, the manufacture of human tissue and cellular and tissue-based products. The 21 CFR Part 1271 regulation was enforced as of May 25, 2005...
Download above file for full tables and figures, or for overview, see HTML Version.
|
|
Particle Measuring Systems' Software and GAMP® 21 CFR Part 11 Compliance (92.9 KB)
Pharmaceutical companies have historically submitted product applications to the Food and Drug Administration (FDA) on paper. With the advent of technology this is now dominated with electronic data records and electronic submissions. This change in philosophy has meant that in the FDA's...
Download above file for full tables and figures, or for overview, see HTML Version.
|
|
How Many Particles, How Much Sample Volume? (254.3 KB)
How many particles are needed to demonstrate statistical confidence for cleanroom control and how much sample volume is required to see them?
Download above file for full tables and figures, or for overview, see HTML Version.
|
|
Process Analytical Technologies (PAT) and Non-viable Particle Counting (116.7 KB)
Pharmaceutical manufacturing environments have traditionally seen particle counting as a necessary evil to demonstrate compliance to a cleanrooms standard. Now, however, Process Analytical Technologies (PAT) changes the focus to be on the final quality of the product. To achieve this...
Download above file for full tables and figures, or for overview, see HTML Version.
|
|
Wireless Particle Monitoring of Cleanrooms (1.0 MB)
This article explains how wireless technology can improve the way that particles are monitored within pharmaceutical cleanrooms, while meeting validation and calibration requirements.
Download above file for full tables and figures, or for overview, see HTML Version.
|
WEBCAST: The Plain Truth About USP 797
This
webcast
can be attended live on January 30, 2007, or can be viewed on demand until Jan 30, 2008.
|
|